Home  /  Resource Library  /  Obinutuzumab as consolidation after chemo-immunotherapy: Results of the UK National Cancer Research Institute phase II/III GALACTIC trial

Obinutuzumab as consolidation after chemo-immunotherapy: Results of the UK National Cancer Research Institute phase II/III GALACTIC trial

Results of a study investigating obinutuzumab maintenance therapy following chemoimmunotherapy for treatment of chronic lymphocytic leukemia.